IJGP（中文版）

From the Division of Molecular Genetics and Pathology, Office of In Vitro Diagnostics and Radiological Health, Center for Devices and Radiological Health, Food and Drug Administration, Silver Spring, Maryland (J.D.S.)； Departments of Pathology (J.S., R.V., R.J.K.); Gynecology and Obstetrics (R.V., R.J.K.), the Johns Hopkins University School of Medicine, Baltimore, Maryland; and Department of Pathology and Laboratory Medicine, Washington Hospital Center, Washington, District of Columbia (J.K.).

The opinions and assertions herein are the private views of the authors and do not purport to reflect the position of the US FDA or any other part of the US Government. This work is unrelated to FDA and was not prepared under official government duties.

The authors declare no conflict of interest.

Address correspondence and reprint requests to Jeffrey D. Seidman, MD, Division of Molecular Genetics and Pathology, Office of In Vitro Diagnostics and Radiological Health, Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Ave., Silver Spring, MD 20993. E-mail: jeffrey.seidman@fda.hhs.gov.